UBS’s Cellcom Israel, Ltd. CEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.06M Buy
96,689
+89,407
+1,228% +$1.06M ﹤0.01% 3525
2014
Q2
$88K Sell
7,282
-869
-11% -$11.4K ﹤0.01% 6098
2014
Q1
$113K Sell
8,151
-11,812
-59% -$152K ﹤0.01% 5836
2013
Q4
$277K Sell
19,963
-18,349
-48% -$233K ﹤0.01% 4936
2013
Q3
$423K Sell
38,312
-433,980
-92% -$4.65M ﹤0.01% 4325
2013
Q2
$4.36M Buy
+472,292
New +$4.29M 0.01% 1759

Other funds holding CEL

UBS's CEL Position: Q3 2014 in Review

UBS increased its Cellcom Israel, Ltd. (CEL) stake by 1,228% in Q3 2014, buying an estimated $1.06M and bringing the position to 96,689 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3525.

UBS first reported a position in CEL in Q2 2013 and has held it in 6 quarters since. The position peaked at $4.36M in Q2 2013. 44 funds tracked by Wall St. Rank hold CEL as of Q3 2014.

  • UBS held 96,689 shares of Cellcom Israel, Ltd. worth $1.06M as of Q3 2014.
  • UBS bought 89,407 Cellcom Israel, Ltd. shares in Q3 2014, an estimated $1.06M.
  • Cellcom Israel, Ltd. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3525 holding.
  • UBS first reported a position in Cellcom Israel, Ltd. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cellcom Israel, Ltd. position peaked at $4.36M in Q2 2013.
  • 44 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.